280 related articles for article (PubMed ID: 28297625)
41. The Biology of Classic Hairy Cell Leukemia.
Bohn JP; Salcher S; Pircher A; Untergasser G; Wolf D
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360545
[TBL] [Abstract][Full Text] [Related]
42. Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.
Maitre E; Tomowiak C; Lebecque B; Bijou F; Benabed K; Naguib D; Kerneves P; Cornet E; Viailly PJ; Arsham J; Sola B; Jardin F; Troussard X
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454811
[TBL] [Abstract][Full Text] [Related]
43. Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAF V600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays.
Brown NA; Weigelin HC; Bailey N; Laliberte J; Elenitoba-Johnson KS; Lim MS; Betz BL
Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):590-600. PubMed ID: 24503706
[TBL] [Abstract][Full Text] [Related]
44. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
[TBL] [Abstract][Full Text] [Related]
45. How I manage patients with hairy cell leukaemia.
Thompson PA; Ravandi F
Br J Haematol; 2017 May; 177(4):543-556. PubMed ID: 28146266
[TBL] [Abstract][Full Text] [Related]
46. Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.
Sári E; Nagy ZG; Baghy K; Rajnai H; Bödör C; Csomor J; Barna G; Rudas G; Kovalszky I; Demeter J
Pathol Oncol Res; 2014 Oct; 20(4):973-80. PubMed ID: 24789721
[TBL] [Abstract][Full Text] [Related]
47. New Targeted Therapy Combination Holds Promise to Untangle Hairy Cell Leukemia.
Soong D; Taylor J
NEJM Evid; 2023 Oct; 2(10):EVIDe2300173. PubMed ID: 38320184
[TBL] [Abstract][Full Text] [Related]
48. Recurrent CDKN1B (p27) mutations in hairy cell leukemia.
Dietrich S; Hüllein J; Lee SC; Hutter B; Gonzalez D; Jayne S; Dyer MJ; Oleś M; Else M; Liu X; Słabicki M; Wu B; Troussard X; Dürig J; Andrulis M; Dearden C; von Kalle C; Granzow M; Jauch A; Fröhling S; Huber W; Meggendorfer M; Haferlach T; Ho AD; Richter D; Brors B; Glimm H; Matutes E; Abdel Wahab O; Zenz T
Blood; 2015 Aug; 126(8):1005-8. PubMed ID: 26065650
[TBL] [Abstract][Full Text] [Related]
49. Refractory and relapsed hairy-cell leukemia (HCL): casting light on promising experimental drugs in clinical trials.
Robak T; Robak P
Expert Opin Investig Drugs; 2023 Apr; 32(4):311-324. PubMed ID: 36931901
[TBL] [Abstract][Full Text] [Related]
50. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Cornet E
Am J Hematol; 2017 Dec; 92(12):1382-1390. PubMed ID: 29110361
[TBL] [Abstract][Full Text] [Related]
51. Biology and Treatment of Hairy Cell Leukemia.
Paillassa J; Troussard X
Curr Treat Options Oncol; 2020 Apr; 21(6):44. PubMed ID: 32350628
[TBL] [Abstract][Full Text] [Related]
52. BRAF inhibition in hairy cell leukemia with low-dose vemurafenib.
Dietrich S; Pircher A; Endris V; Peyrade F; Wendtner CM; Follows GA; Hüllein J; Jethwa A; Ellert E; Walther T; Liu X; Dyer MJ; Elter T; Brummer T; Zeiser R; Hermann M; Herold M; Weichert W; Dearden C; Haferlach T; Seiffert M; Hallek M; von Kalle C; Ho AD; Gaehler A; Andrulis M; Steurer M; Zenz T
Blood; 2016 Jun; 127(23):2847-55. PubMed ID: 26941398
[TBL] [Abstract][Full Text] [Related]
53. [Detection of BRAF V600E mutation in hairy cell leukemia by high- resolution melting analysis].
Zhang Y; Liu H; Qi J; Liu W; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):207-9. PubMed ID: 24666485
[TBL] [Abstract][Full Text] [Related]
54. Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia.
Ewalt M; Nandula S; Phillips A; Alobeid B; Murty VV; Mansukhani MM; Bhagat G
Hematol Oncol; 2012 Dec; 30(4):190-3. PubMed ID: 22246856
[TBL] [Abstract][Full Text] [Related]
55. Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment.
Polderdijk MCE; Heron M; Kuipers S; Rijkers GT
Expert Rev Clin Immunol; 2019 Aug; 15(8):857-867. PubMed ID: 31282776
[No Abstract] [Full Text] [Related]
56. New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.
Maitre E; Bertrand P; Maingonnat C; Viailly PJ; Wiber M; Naguib D; Salaün V; Cornet E; Damaj G; Sola B; Jardin F; Troussard X
Oncotarget; 2018 Jun; 9(48):28866-28876. PubMed ID: 29989027
[TBL] [Abstract][Full Text] [Related]
57. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
[No Abstract] [Full Text] [Related]
58. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.
Xi L; Arons E; Navarro W; Calvo KR; Stetler-Stevenson M; Raffeld M; Kreitman RJ
Blood; 2012 Apr; 119(14):3330-2. PubMed ID: 22210875
[TBL] [Abstract][Full Text] [Related]
59. NFkB is activated by multiple mechanisms in hairy cell leukemia.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Genes Chromosomes Cancer; 2015 Jul; 54(7):418-32. PubMed ID: 25960206
[TBL] [Abstract][Full Text] [Related]
60. Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders.
Laurini JA; Aoun P; Iqbal J; Chan W; Greiner TC
Am J Clin Pathol; 2012 Dec; 138(6):877-83. PubMed ID: 23161722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
